Assessment of chemotherapy-related educational needs of colorectal cancer patients [0.03%]
结直肠癌患者化疗相关教育需求的评估
Songul Tezcan,Gökçen İlke Tanır,Hayriye Yılmaz et al.
Songul Tezcan et al.
Aim: Aim of our study was to evaluate cancer patients' knowledge about their chemotherapy regimens in order to assess educational needs of patients. Metho...
Protective effects of Panax ginseng against doxorubicin-induced cardiac toxicity in patients with non-metastatic breast cancer: A randomized, double-blind, placebo-controlled clinical trial [0.03%]
人参对非转移性乳腺癌患者多柔比星所致的心脏毒性的保护作用：一项随机、双盲、安慰剂对照临床试验
Malihe Hamidian,Farzaneh Foroughinia,Shirin Haghighat et al.
Malihe Hamidian et al.
Introduction: Anthracycline-based chemotherapy increases the risk of cancer therapeutics-related cardiac dysfunction. Recently, evidences from in vitro experiments and animal studies have shown that ginsenosides may exert...
Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendations [0.03%]
2022年乳腺癌治疗靶点的预后和预测生物标志物现状、证据及建议更新
Clement Chung,Vanessa T Y Yeung,Kenneth C W Wong
Clement Chung
Objective: To evaluate and validate the recent and emerging data for prognostic and predictive biomarkers with therapeutic targets in breast cancer. Data ...
Real-world analysis of tumor lysis syndrome in patients started on venetoclax combination for acute myeloid leukemia [0.03%]
维奈克拉联合用药治疗急性髓系白血病患者肿瘤溶解综合征的现实世界分析
Karin M Abernathy,Matthew A Perciavalle,Katie S Gatwood et al.
Karin M Abernathy et al.
Introduction: Venetoclax is utilized with low-dose cytarabine or a hypomethylating agent for the treatment of acute myeloid leukemia. Clinical trials report a risk of tumor lysis syndrome and the package insert recommends...
Perceptions and prevalence of marijuana use among cancer patients managed at an outpatient department in Zimbabwe: A brief report [0.03%]
津巴布韦一家门诊部管理的癌症患者中大麻使用的感知和流行率简报
Maudy Cp Manyau,Kudzanai P Changadzo,Tinashe Mudziti
Maudy Cp Manyau
Background: Globally, marijuana is becoming an acceptable complementary medicine for symptom management in cancer. At the time that the study was conducted, Zimbabwean laws only allowed for the cultivation of marijuana fo...
Jina Yun,Reid Nakagawa,Kenneth Tham
Jina Yun
Objective: KRAS mutations are one of the most common driver mutations in non-small cell lung cancer. Though previously believed to be an undruggable target, recent advances in therapeutics have seen new targeted agents ag...
Smartphone-based application and nurses' interventions for symptoms monitoring in patients treated with oral anticancer agents: A 1-year follow-up in a tertiary cancer center [0.03%]
基于智能手机的应用程序和护士干预在口服抗癌药物治疗患者症状监测中的作用：一项三级癌症中心的1年随访研究
Laura Porcher,Valérie Perron,Julie Blanc et al.
Laura Porcher et al.
Aim: The increasing use of oral anticancer agents over the past years has necessitated changes in monitoring toxicities to ensure patients' adherence and tolerance at home. The aim of this study was to describe nurses' in...
Evaluating aggressiveness of end-of-life care in patients with advanced cancer: A retrospective single-center analysis [0.03%]
晚期癌症患者生命终期护理的激进性评估：一项回顾性单中心分析
Araceli Iglesias-Santamaría
Araceli Iglesias-Santamaría
Introduction: Overuse of anti-cancer therapy near end of life is an important quality-of-care issue. An aggressive approach to treatment can have negative effects on the quality of life and cost of hospital-based resource...
Contribution of an anticancer drug compounding robot in reducing the risks of manual preparation in a hospital pharmacy unit specialized in oncology [0.03%]
自动化抗癌药物配置机器人在医院肿瘤药房手动配药风险中的作用分析
Ali Cherif Chefchaouni,Yassine Boudina,Meryem Chennaq et al.
Ali Cherif Chefchaouni et al.
Introduction: In the last few years, pharmaceutical technology has evolved. In the field of oncology pharmacy, robots for the preparation of anti-cancer drugs have appeared to progressively replace manual preparation. The...
Nivolumab-ipilimumab combination therapy-induced seronegative encephalitis; rapid response to steroid plus intravenous immunoglobulin (IVIG) treatment [0.03%]
尼伏单抗-易普利姆玛联合治疗诱导的自身免疫性无抗体脑炎;皮质类固醇和静脉注射免疫球蛋白治疗有效
Kadriye Bir Yucel,Osman Sutcuoglu,Ozan Yazıcı et al.
Kadriye Bir Yucel et al.
Introduction: The efficacy of immune checkpoint inhibitors (ICIs) against malignant melanoma and numerously solid tumors has been demonstrated in several clinical studies. The incidence of immune-related adverse effects (...